Binbin Gong , Han Zhang , Siwei Li , Yunhe Lin , Shuaimei Xu , Bo Jia , Yu Lu , Zhongjun Liu
{"title":"Strategies for enhancing biocompatibility, bioactivity, and resistance to biodegradation in dental resin composites: A narrative review","authors":"Binbin Gong , Han Zhang , Siwei Li , Yunhe Lin , Shuaimei Xu , Bo Jia , Yu Lu , Zhongjun Liu","doi":"10.1016/j.bioadv.2025.214496","DOIUrl":null,"url":null,"abstract":"<div><div>Dental resin composites (DRCs), while indispensable in restorative dentistry for addressing tooth defects, are constrained by several inherent limitations. Conventional DRCs not only have cytotoxic potential but also undergo accelerated biodegradation mediated by host-derived enzymes and oral microbiota. Additionally, conventional DRCs are inherently bioinert—lacking the bioactivity required to inhibit the initiation and progression of secondary caries. Existing studies have found that degradation byproducts of DRCs may enhance the virulence of cariogenic pathogens. Concurrently, microleakage at resin-dentin interfaces causes salivary permeation and biofilm colonization, collectively establishing a pathogenic ‘degradation-infection’ feedback cycle. Furthermore, residual monomer release during biodegradation exacerbates cytotoxic responses, thereby generating synergistic “degradation-toxicity” compounding effects. These compounding effects severely compromise the clinical longevity and functional stability of DRC-based restorations. Therefore, this review comprehensively examines the factors and mechanisms underlying the cytotoxicity and biodegradation of conventional DRCs in oral environments from both bacterial and host perspectives. It also discusses their early-stage application profile characterized by “mere structural repair”—reflecting bioinertness. In addition, this review places particular focus on design strategies for novel DRCs intended to overcome these limitations and to impart improved biological performance. This review provides a theoretical framework for the biological optimization of DRCs and offers new ideas for developing next-generation DRCs with both biological safety and clinical durability.</div></div>","PeriodicalId":51111,"journal":{"name":"Materials Science & Engineering C-Materials for Biological Applications","volume":"179 ","pages":"Article 214496"},"PeriodicalIF":6.0000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materials Science & Engineering C-Materials for Biological Applications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772950825003231","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Dental resin composites (DRCs), while indispensable in restorative dentistry for addressing tooth defects, are constrained by several inherent limitations. Conventional DRCs not only have cytotoxic potential but also undergo accelerated biodegradation mediated by host-derived enzymes and oral microbiota. Additionally, conventional DRCs are inherently bioinert—lacking the bioactivity required to inhibit the initiation and progression of secondary caries. Existing studies have found that degradation byproducts of DRCs may enhance the virulence of cariogenic pathogens. Concurrently, microleakage at resin-dentin interfaces causes salivary permeation and biofilm colonization, collectively establishing a pathogenic ‘degradation-infection’ feedback cycle. Furthermore, residual monomer release during biodegradation exacerbates cytotoxic responses, thereby generating synergistic “degradation-toxicity” compounding effects. These compounding effects severely compromise the clinical longevity and functional stability of DRC-based restorations. Therefore, this review comprehensively examines the factors and mechanisms underlying the cytotoxicity and biodegradation of conventional DRCs in oral environments from both bacterial and host perspectives. It also discusses their early-stage application profile characterized by “mere structural repair”—reflecting bioinertness. In addition, this review places particular focus on design strategies for novel DRCs intended to overcome these limitations and to impart improved biological performance. This review provides a theoretical framework for the biological optimization of DRCs and offers new ideas for developing next-generation DRCs with both biological safety and clinical durability.
期刊介绍:
Biomaterials Advances, previously known as Materials Science and Engineering: C-Materials for Biological Applications (P-ISSN: 0928-4931, E-ISSN: 1873-0191). Includes topics at the interface of the biomedical sciences and materials engineering. These topics include:
• Bioinspired and biomimetic materials for medical applications
• Materials of biological origin for medical applications
• Materials for "active" medical applications
• Self-assembling and self-healing materials for medical applications
• "Smart" (i.e., stimulus-response) materials for medical applications
• Ceramic, metallic, polymeric, and composite materials for medical applications
• Materials for in vivo sensing
• Materials for in vivo imaging
• Materials for delivery of pharmacologic agents and vaccines
• Novel approaches for characterizing and modeling materials for medical applications
Manuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Materials Science and Engineering C. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.
Biomaterials Advances sits within Elsevier''s biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!